Logo image of EPSM

EPSIUM ENTERPRISE LTD (EPSM) Stock Fundamental Analysis

NASDAQ:EPSM - Nasdaq - VGG3090S1065 - Common Stock - Currency: USD

14.3  +0.3 (+2.14%)

Fundamental Rating

5

Taking everything into account, EPSM scores 5 out of 10 in our fundamental rating. EPSM was compared to 17 industry peers in the Distributors industry. While EPSM has a great health rating, its profitability is only average at the moment. EPSM is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

EPSM had positive earnings in the past year.
In the past year EPSM has reported a negative cash flow from operations.
EPSM Yearly Net Income VS EBIT VS OCF VS FCFEPSM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 1M 2M 3M 4M

1.2 Ratios

The Return On Assets of EPSM (41.66%) is better than 100.00% of its industry peers.
With an excellent Return On Equity value of 50.08%, EPSM belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
EPSM has a better Return On Invested Capital (49.83%) than 100.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for EPSM is significantly above the industry average of 17.10%.
The last Return On Invested Capital (49.83%) for EPSM is above the 3 year average (35.19%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 41.66%
ROE 50.08%
ROIC 49.83%
ROA(3y)22.51%
ROA(5y)N/A
ROE(3y)36.7%
ROE(5y)N/A
ROIC(3y)35.19%
ROIC(5y)N/A
EPSM Yearly ROA, ROE, ROICEPSM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 10 20 30 40

1.3 Margins

With an excellent Profit Margin value of 11.39%, EPSM belongs to the best of the industry, outperforming 94.12% of the companies in the same industry.
Looking at the Operating Margin, with a value of 13.43%, EPSM belongs to the top of the industry, outperforming 94.12% of the companies in the same industry.
EPSM has a Gross Margin of 17.83%. This is comparable to the rest of the industry: EPSM outperforms 41.18% of its industry peers.
Industry RankSector Rank
OM 13.43%
PM (TTM) 11.39%
GM 17.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EPSM Yearly Profit, Operating, Gross MarginsEPSM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 5 10 15

More info and screens

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so EPSM is creating value.
Compared to 1 year ago, EPSM has about the same amount of shares outstanding.
There is no outstanding debt for EPSM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
EPSM Yearly Shares OutstandingEPSM Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2M 4M 6M 8M 10M
EPSM Yearly Total Debt VS Total AssetsEPSM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2M 4M 6M 8M 10M

2.2 Solvency

An Altman-Z score of 75.01 indicates that EPSM is not in any danger for bankruptcy at the moment.
EPSM has a Altman-Z score of 75.01. This is amongst the best in the industry. EPSM outperforms 100.00% of its industry peers.
EPSM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 75.01
ROIC/WACC5.57
WACC8.94%
EPSM Yearly LT Debt VS Equity VS FCFEPSM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2M 4M 6M

2.3 Liquidity

EPSM has a Current Ratio of 6.57. This indicates that EPSM is financially healthy and has no problem in meeting its short term obligations.
EPSM has a better Current ratio (6.57) than 94.12% of its industry peers.
A Quick Ratio of 3.45 indicates that EPSM has no problem at all paying its short term obligations.
EPSM's Quick ratio of 3.45 is amongst the best of the industry. EPSM outperforms 88.24% of its industry peers.
Industry RankSector Rank
Current Ratio 6.57
Quick Ratio 3.45
EPSM Yearly Current Assets VS Current LiabilitesEPSM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 228.94% over the past year.
Looking at the last year, EPSM shows a very strong growth in Revenue. The Revenue has grown by 161.30%.
EPS 1Y (TTM)228.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-86.78%
Revenue 1Y (TTM)161.3%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-61.34%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPSM Yearly Revenue VS EstimatesEPSM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 5M 10M 15M 20M 25M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 46.13, the valuation of EPSM can be described as expensive.
EPSM's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of EPSM to the average of the S&P500 Index (23.99), we can say EPSM is valued expensively.
Industry RankSector Rank
PE 46.13
Fwd PE N/A
EPSM Price Earnings VS Forward Price EarningsEPSM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as EPSM.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 38.41
EPSM Per share dataEPSM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

The decent profitability rating of EPSM may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

EPSM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EPSIUM ENTERPRISE LTD

NASDAQ:EPSM (5/8/2025, 12:52:18 PM)

14.3

+0.3 (+2.14%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryDistributors
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap192.19M
AnalystsN/A
Price TargetN/A
Short Float %0.02%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 46.13
Fwd PE N/A
P/S 5.29
P/FCF N/A
P/OCF N/A
P/B 23.27
P/tB 23.27
EV/EBITDA 38.41
EPS(TTM)0.31
EY2.17%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS2.7
BVpS0.61
TBVpS0.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 41.66%
ROE 50.08%
ROCE 57.62%
ROIC 49.83%
ROICexc 51.89%
ROICexgc 51.89%
OM 13.43%
PM (TTM) 11.39%
GM 17.83%
FCFM N/A
ROA(3y)22.51%
ROA(5y)N/A
ROE(3y)36.7%
ROE(5y)N/A
ROIC(3y)35.19%
ROIC(5y)N/A
ROICexc(3y)40.39%
ROICexc(5y)N/A
ROICexgc(3y)40.39%
ROICexgc(5y)N/A
ROCE(3y)41.3%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover3.66
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 576.39%
Cap/Sales 0.23%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.57
Quick Ratio 3.45
Altman-Z 75.01
F-ScoreN/A
WACC8.94%
ROIC/WACC5.57
Cap/Depr(3y)8.84%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.02%
Cap/Sales(5y)N/A
Profit Quality(3y)90.01%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)228.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-86.78%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)161.3%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-61.34%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y250.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y33.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y33.41%
OCF growth 3YN/A
OCF growth 5YN/A